AstraZeneca Pharma India Ltd. — Regulatory Filings 2021

Jan 27, 2021

==> picture [524 x 91] intentionally omitted <==

January 25, 2021

The Manager –Listing

BSE Limited

Corporate Relationship Dept., 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

National Stock Exchange of India Ltd.

Exchange plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

Dear Sir,

Sub: Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

We are enclosing herewith Certificate dated January 1, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Please take the same on record.

Yours faithfully, For AstraZeneca Pharma India Limited

PRATAP Digitally signed RUDRA by PRATAP RUDRA BHUVANA BHUVANAGIRI Date: 2021.01.25 GIRI 18:01:25 +05'30'

Pratap Rudra

Company Secretary & Legal Counsel

Encl: as above

==> picture [452 x 64] intentionally omitted <==

==> picture [149 x 36] intentionally omitted <==

==> picture [80 x 42] intentionally omitted <==

==> picture [272 x 161] intentionally omitted <==

==> picture [510 x 218] intentionally omitted <==

==> picture [153 x 59] intentionally omitted <==

Checked by :

==> picture [52 x 25] intentionally omitted <==

==> picture [378 x 80] intentionally omitted <==